Idiopathic pulmonary fibrosis Trials in London, United Kingdom
Conditions / Idiopathic pulmonary fibrosis / London, United Kingdom
Research into Idiopathic pulmonary fibrosis spans multiple therapeutic approaches and trial phases.
56 total trials for this combination
Showing top 10 of 56 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT06097260 | Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary Fibrosis | TERMINATED | PHASE2 |
| NCT06238622 | A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast | RECRUITING | — |
| NCT00768300 | (ARTEMIS-IPF) Randomized, Placebo-Controlled Study to Evaluate Safety and Effectiveness of Ambrisentan in IPF | TERMINATED | PHASE3 |
| NCT05321069 | A Study to Find Out Whether BI 1015550 Improves Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) | COMPLETED | PHASE3 |
| NCT06683612 | PET Study of PIPE-791 in Healthy Volunteers and Volunteers With PrMS and IPF | COMPLETED | PHASE1 |
| NCT04552899 | A Study to Evaluate the Efficacy and Safety of Recombinant Human Pentraxin-2 (rhPTX-2; PRM-151) in Participants With Idiopathic Pulmonary Fibrosis | TERMINATED | PHASE3 |
| NCT06238622 | A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast | RECRUITING | — |
| NCT06003426 | A Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT00879229 | ARTEMIS-PH - Study of Ambrisentan in Subjects With Pulmonary Hypertension Associated With Idiopathic Pulmonary Fibrosis | TERMINATED | PHASE3 |
| NCT01769196 | Study to Assess the Efficacy and Safety of Simtuzumab (GS-6624) in Adults With Idiopathic Pulmonary Fibrosis (IPF) | TERMINATED | PHASE2 |